Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Bioavailability Study of a Single Dose of Ziltivekimab Formulation B in a Manual Syringe, Formulation D in a Manual Syringe and Formulation C in a Pen-injector

NCT05721989 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT05721989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05721989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Bioavailability Study of a Single Dose of Ziltivekimab Formulation B in a Manual Syringe, Formulation D in a Manual Syringe and Formulation C in a Pen-injector
Lead sponsor
Novo Nordisk A/S
Phase
Phase 1
Overall status
Completed
Start date
February 3, 2023
Completion date
January 8, 2024
Enrollment
267 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants